Zydus Lifesciences informs about press release

31 Jul 2024 Evaluate
Zydus Lifesciences has enclosed a copy of press release dated July 31, 2024 titled ‘Zydus receives approval from COFEPRIS of Mexico to market Mamitra (Trastuzumab biosimilar) to treat various cancers’. The contents of the press release give full details. 

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

914.65 13.35 (1.48%)
31-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.75
Dr. Reddys Lab 1271.05
Cipla 1510.90
Zydus Lifesciences 914.65
Lupin 2112.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×